Our hypothesis proposes that monocyte-derived M2 macrophages produce angiogenic and anti-inflammatory factors, such as IL-10 and TGFB ligands, to promote regulatory T-cell infiltration in the TME, leading to the downregulation of the immune response to the tumor [29,30,31]. Here, TGFB1 is linked to neoplasm.